Rab3B immunoexpression in human pituitary adenomas

Applied Immunohistochemistry and Molecular Morphology

Volumn 17, Issue 3, 2009, Pages 185-188

  Rotondo, Fabio ^a   Scheithauer, Bernd W ^b   Kovacs, Kalman ^a   Bell, David C ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b MAYO CLINIC   (United States)

Author keywords

Immunohistochemistry; Pathology; Pituitary; Pituitary neoplasm; Rab3B

Indexed keywords

BROMOCRIPTINE; OCTREOTIDE; RAB PROTEIN; RAB3B PROTEIN; UNCLASSIFIED DRUG; RAB3B PROTEIN, HUMAN;

ACTH SECRETING ADENOMA; ADENOHYPOPHYSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GONADOTROPH ADENOMA; GROWTH HORMONE SECRETING ADENOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NULL CELL ADENOMA; PREOPERATIVE CARE; PRIORITY JOURNAL; PROLACTINOMA; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; THYROTROPIN SECRETING ADENOMA; ADENOMA; CYTOLOGY; HYPOPHYSIS; HYPOPHYSIS TUMOR; METABOLISM; PATHOLOGY;

ADENOMA; BROMOCRIPTINE; HUMANS; OCTREOTIDE; PITUITARY GLAND; PITUITARY NEOPLASMS; RAB3 GTP-BINDING PROTEINS;

EID: 66549110062     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e31818fa0ed     Document Type: Article

References (34)

1. Jahn R, Sudhof TC. Membrane fusion and exocytosis. Annu Rev Biochem. 1999;68:863-911.
2. Jahn R, Lang T, Sudhof TC. Membrane fusion. Cell. 2003;112: 519-533.
3. Bonifacino JS, Glick BS. The mechanisms of vesicle budding and fusion. Cell. 2004;116:153-166.
4. Weber E, Jilling T, Kirk KL. Distinct functional properties of Rab3A and Rab3B in PC12 neuroendocrine cells. J Biol Chem. 1996;271:6963-6971. (Pubitemid 26104792)
5. Darchen F, Zahraoui A, Hammel F, et al. Association of the GTPbinding protein Rab3A with bovine adrenal chromaffin granules. Proc Natl Acad Sci USA. 1990;87:5692-5696. (Pubitemid 20240353)
6. Mollard GF, Mignery GA, Baumert M, et al. Rab3 is a small GTPbinding protein exclusively localized to synaptic vesicles. Proc Natl Sci USA. 1990;87:1988-1992. (Pubitemid 20098098)
7. Matteoli M, Takei K, Cameron R, et al. Association of Rab2A with synaptic vesicles at late stages of the secretory pathway. J Cell Biol. 1991;115:625-633. (Pubitemid 21909918)
8. Martelli AM, Bareggi R, Baldini G, et al. Diffuse vesicular distribution of Rab3D in the polarized neuroendocrine cell line AtT-20. FEBS Letters. 1995;368:271-275.
9. Rupnik M, Kreft M, Nothias F, et al. Distinct role of Rab3A and Rab3B in secretory activity of rat melanotrophs. Am J Physiol Cell Physiol. 2007;292:C98-C105. (Pubitemid 46115123)
10. 2+-dependent exocytosis in rat anterior pituitary cells. Nature. 1993;364:540-544.
11. Redecker P, Cetin Y, Grube D. Differential distribution of synaptotagmin 1 and Rab3 in anterior pituitary of four mammalian species. Neuroendocrinology. 1995;62:101-110.
12. Horvath E, Scheithauer BW, Kovacs K, et al. Hypothalamus and pituitary. In: Graham DI, Lantos PL, eds. Greenfield's Neuropathology. Vol 1. 7th ed. New York, NY: Arnold Publishers; 2002:983-1051.
13. Lloyd RV, Kovacs K, Young WF Jr, et al. Tumors of the pituitary gland. In: DeLellis RA, Lloyd RV, Heitz PU, et al, eds. World Health Organization Classification of Tumours. Tumours of Endocrine Organs. Lyon, France: IARC Press; 2004:9-47.
14. Majo G, Ferrer I, Marsal J, et al. Immunocytochemical analysis of the synaptic proteins SNAP-25 and Rab3A in human pituitary adenomas. Overexpression of SNAP-25 in the mammosomatotroph lineages. J Pathol. 1997;183:440-446. (Pubitemid 27509251)
15. Tasaka K, Masumoto N, Mizuki J, et al. Rab3B is essential for GnRH-induced gonadotropin release from anterior pituitary cells. J Endocrinol. 1998;157:267-274. (Pubitemid 28238030)
16. Tahara S, Sanno N, Teramoto A, et al. Expression of Rab3, a Ras-related GTP-binding protein in human nontumorous pituitaries and pituitary adenomas. Mod Pathol. 1999;12:627-634. (Pubitemid 29279717)
17. Matsuno A, Itoh J, Takekoshi S, et al. Dynamics of subcellular organelles, growth hormone, Rab3b, SNAP-25, and syntaxin in rat pituitary cells caused by growth hormone releasing hormone and somatostatin. Microsc Res Tech. 2003;62:232-239. (Pubitemid 37169755)
18. Nishioka H, Haraoka J. Significance of immunohistochemical expression of Rab3B and SNAP-25 in growth hormone-producing pituitary adenomas. Acta Neuropathol. 2005;109:598-602. (Pubitemid 40974149)
19. Rotondo F, Kovacs K, Horvath E, et al. Immunohistochemical expression of nestin in the non-tumorous hypophysis and in pituitary neoplasms. Acta Neuropathol. 2006;111:272-277.
20. Rotondo F, Kovacs K, Scheithauer BW, et al. Immunohistochemical expression of SNAP-25 protein in adenomas of the human pituitary. Appl Immunohistochem Mol Morphol. 2008;16:477-481.
21. Yamada S, Sano T, Stefaneanu L, et al. Endocrine and morphological study of a clinically silent somatotroph adenoma of the human pituitary. J Clin Endocrinol Metab. 1993;76:352-356. (Pubitemid 23073054)
22. Tindall GT, Kovacs K, Horvath E, et al. Human prolactinproducing adenomas and bromocriptine: a histological, immunocytochemical, ultrastructural and morphometric study. J Clin Endocrinol Metab. 1982;55:1178-1183. (Pubitemid 13204263)
23. Beckers A, Kovacs K, Horvath E, et al. Effect of treatment with octreotide on the morphology of growth hormone-secreting pituitary adenomas: a study of 24 cases. Endocr Pathol. 1991;2:123-131.
24. Stevenaert A, Harris AG, Kovacs K, et al. Presurgical octreotide treatment in acromegaly. Metabolism. 1992;41:51-58.
25. Stefaneanu L, Kovacs K, Scheithauer BW, et al. Effect of dopamine agonists on lactotroph adenomas of the human pituitary. Endocr Pathol. 2000;11:341-352. (Pubitemid 32436869)
26. Kovacs K, Horvath E. Effects of medical therapy on pituitary tumors. Ultrastruct Pathol. 2005;29:163-167. (Pubitemid 40993742)
27. Lopes MB, Pernicone PJ, Scheithauer BW, et al. Pituitary and sellar region. In: Mills SE, ed. Histology for Pathologists. 3rd ed. Philadelphia: Lippincott, Williams & Wilkins; 2006:322-344.
28. Perez F, Lledo PM, Karagogeos D, et al. Rab3A and Rab3B carboxyl-terminal peptides are both potent and specific inhibitors of prolactin release by rat cultured anterior pituitary cells. Mol Endocrinol. 1994;8:1278-1287. (Pubitemid 2152889)
29. Kovacs K, Horvath E, Bayley TA. Silent corticotroph cell adenoma with lysosomal accumulation and crinophagy. A distinct clinicopathologic entity. Am J Med. 1978;64:492-499. (Pubitemid 8302308)
30. Horvath E, Kovacs K, Killinger DW. Silent corticotropic adenomas of the human pituitary gland: a histologic, immunocytologic, and ultrastructural study. Am J Pathol. 1980;98:617-638. (Pubitemid 10154792)
31. Horvath E, Kovacs K, Lloyd RV. Pars intermedia of the human pituitary revisited: morphologic aspects and frequency of hyperplasia of POMC-peptide immunoreactive cells. Endocr Pathol. 1999; 10:55-64. (Pubitemid 29196751)
32. Horvath E, Kovacs K. Misplaced exocytosis. Distinct ultrastructural feature in some pituitary adenomas. Arch Pathol. 1974;97:221-224.
33. Kovacs K, Horvath E, Corenblum B, et al. Pituitary chromophobe and adenomas consisting of prolactin cells: a histologic, immunocytological and electron microscopic study. Virchows Arch A Pathol Anat Histol. 1975;366:113-123.
34. Horvath E, Kovacs K. The adenohypophysis. In: Kovacs K, Asa SL, eds. Functional Endocrine Pathology. 2nd ed. Malden: Blackwell; 1998:247-281.